Live feed
Filing
SCHEDULE 13G
SCHEDULE 13G0001757283-25-000005·Andera Partners
Schedule 13G ownership disclosure
Evommune Inc
Common Stock, $0.0001 par value per share · CUSIP: 30054Y107
Event date: 2025-11-07
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- Andera Partners
Shares: 1,897,362.00 · Class: 6.0%
- BioDiscovery 6 FPCI
Shares: 1,897,362.00 · Class: 6.0%
- Stephane Bergez
Shares: 1,897,362.00 · Class: 6.0%
- Francois Xavier Mauron
Shares: 1,897,362.00 · Class: 6.0%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001757283-25-000005
- Form type
- SCHEDULE 13G
- Filer
- Andera Partners
- CIK
- CIK 1757283
- Filed
- Nov 17, 2025
- Reporting period
- Nov 07, 2025
- Description
- Schedule 13G beneficial ownership